Literature DB >> 17270358

Profile of dependence symptoms among extramedical opioid analgesic users.

Silvia S Martins1, Lilian A Ghandour, Howard D Chilcoat.   

Abstract

Little is known about the extent of problems due to extramedical opioid analgesic use ('analgesic misuse') in the US general population. This study explores the distribution of the seven DSM-IV-defined past-year dependence symptoms in a total household sample of 7,810 past-year extramedical opioid analgesic users using the 2002-2003 National Survey on Drug Use and Health (NSDUH). We tested for differences in opioid analgesic dependence symptom profiles across four subgroups of opioid analgesic users, different levels of deviant behaviors, and presence/absence of serious mental health problems quantified by the Composite International Diagnostic Interview Short Form (CIDI-sf). Generalized Estimated Equations (GEE) models were used to analyze the data. The most common opioid analgesic dependence symptoms were 'tolerance' (17.0%) and 'salience' (13.3%). Opioid analgesic dependence symptom profiles were 'parallel' across the groups of past-year opioid analgesic users, across deviant behavior groups and across presence/absence of serious mental health problems. Extramedical use of opioid analgesics associated with prescription drug use, having high levels of deviant behaviors, and having serious mental health problems were more strongly associated with endorsement of opioid analgesics dependence symptoms.

Mesh:

Substances:

Year:  2007        PMID: 17270358     DOI: 10.1016/j.addbeh.2007.01.006

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  9 in total

1.  Understanding the patterns and distribution of opioid analgesic dependence symptoms using a latent empirical approach.

Authors:  L A Ghandour; S S Martins; H D Chilcoat
Journal:  Int J Methods Psychiatr Res       Date:  2008       Impact factor: 4.035

2.  Transitioning from First Drug Use to Dependence Onset: Illustration of a Multiparametric Approach for Comparative Epidemiology.

Authors:  Olga A Vsevolozhskaya; James C Anthony
Journal:  Neuropsychopharmacology       Date:  2015-07-15       Impact factor: 7.853

3.  Nonmedical Opioid Pain Relievers and All-Cause Mortality: A 27-Year Follow-Up From the Epidemiologic Catchment Area Study.

Authors:  Linda B Cottler; Hui Hu; Bryan A Smallwood; James C Anthony; Li-Tzy Wu; William W Eaton
Journal:  Am J Public Health       Date:  2015-12-21       Impact factor: 9.308

4.  Data Sources Regarding the Nonmedical Use of Pharmaceutical Opioids in the United States.

Authors:  Teresa Schmidt; Amanuel Zimam; Alexandra Nielsen; Wayne Wakeland
Journal:  Rev Health Care       Date:  2014

Review 5.  Health harms of non-medical prescription opioid use: A systematic review.

Authors:  Dan Werb; Ayden I Scheim; Ayorinde Soipe; Samantha Aeby; Indhu Rammohan; Benedikt Fischer; Scott E Hadland; Brandon D L Marshall
Journal:  Drug Alcohol Rev       Date:  2022-04-18

6.  Prescription pain reliever abuse and dependence among adolescents: a nationally representative study.

Authors:  Li-Tzy Wu; Christopher L Ringwalt; Paolo Mannelli; Ashwin A Patkar
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-09       Impact factor: 8.829

7.  Drug use and high-risk sexual behaviors among african american men who have sex with men and men who have sex with women.

Authors:  Dorothy C Browne; Patricia A Clubb; Yan Wang; Fernando Wagner
Journal:  Am J Public Health       Date:  2009-04-16       Impact factor: 9.308

8.  Epidemiological evidence on extra-medical use of prescription pain relievers: transitions from newly incident use to dependence among 12-21 year olds in the United States using meta-analysis, 2002-13.

Authors:  Maria A Parker; James C Anthony
Journal:  PeerJ       Date:  2015-10-20       Impact factor: 2.984

9.  Gender-specific differences in high-risk sexual behaviors among methamphetamine users in Myanmar-China border city, Muse, Myanmar: who is at risk?

Authors:  Yu Mon Saw; Thu Nandar Saw; Nyein Chan; Su Myat Cho; Masamine Jimba
Journal:  BMC Public Health       Date:  2018-02-01       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.